Preview

Rheumatology Science and Practice

Advanced search

CLINICAL CHARACTERISTICS OF THREE COHORTS OF PATIENTS WITH EARLY- AND LATE-ONSET RHEUMATOID ARTHRITIS (AT 50 YEARS OR OLDER). GENERALIZATION OF 40 YEARS’ EXPERIENCE

https://doi.org/10.14412/1995-4484-2020-140-146

Abstract

The paper presents three cohorts of patients with early rheumatoid arthritis (RA) who fell ill at 50 years or older and had a disease duration of 1.5 months to 1 year. To establish its diagnosis, the investigators used classification criteria for each cohort of its period: 1) the 1958 American Rheumatism Association (ARA) criteria; 2) the 1987 ARA criteria, and 3) the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria. Along with a change in the criteria, diagnostic methods were improved in this period. Many qualitative laboratory parameters were replaced with their quantitative equivalent; new disease markers (including anti-cyclic citrullinated peptide antibodies) emerged; imaging methods were improved; treatment policies were changed, and targeted biological agents and numerous analogs of the original drugs appeared.
Conflicting opinions about the course of RA in older age groups have repeatedly been published in the literature. In the period when the 1958 classification criteria were applied, the opinion that RA has a relatively favorable course was prevalent. Later on, when a more rigid approach to diagnosing RA was applied, there were more and more specialists who considered it to be a severe disease. In this study, the authors try to answer the question of whether the course of the disease changed in the older age groups at the earliest possible date after its onset, by comparing the three cohorts of patients. The findings are discussed.


About the Authors

A. M. Satybaldyev
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


N. V. Demidova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


G. I. Gridneva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


N. Yu. Nikishina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


E. V. Gerasimova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


D. A. Gukasian
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


K. A. Kasumova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


E. L. Luchikhina
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
61/2, Shchepkin St., Build 1, Moscow 129110



A. S. Misiyuk
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


T. G. Oskilko
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


O. A. Rumyantseva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


E. A. Zlepko
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


L. N. Tyurina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


E. V. Fedorenko
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


N. V. Shornikova
V.A. Nasonova Research Institute of Rheumatology; Joint and Heart Treatment Center
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522

4, Nizhnyaya Krasnoselskaya St., Moscow 107140



E. L. Nasonov
V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522

48, Trubetskaya St., Build. 2, Moscow 119991





References

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205-19. doi: 10.1056/NEJMra1004965

2. Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27:864-72. doi: 10.1002/art.1780270805

3. Van der Heide A, Jacobs JW, Bijlsma JW, et al. The effectiveness of early treatment with «second-line» antirheumatic drugs: a randomized, controlled trial. Ann Intern Med. 1996;124:699-707. doi: 10.7326/0003-4819-124-8-199604150-00001

4. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26:S35-S61.

5. Quartuccio L, Fabris M, Salvin S, et al. Rheumatoid factor positivity rather then ant-CCP positivity, a lower disability and a lower number anti-TNF agents failed are associated with response to Rituximab in rheumatoid arthritis. Rheumatology. 2009;48(5):1557-9. doi: 10.1093/rheumatology/kep314

6. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094-108. doi: 10.1016/S0140-6736(10)60826-4

7. Haraoui B, Pope J. Treatment of early rheumatoid arthritis: concepts in management. Semin Arthritis Rheum. 2011;40:371-88. doi: 10.1016/j.semarthrit.2010.10.004

8. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797-808. doi: 10.7326/0003-4819-146-11-200706050-00008

9. Calvo-Alen J, Corrales A, Sanchez-Andrada S, et al. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol. 2005;24:485-9. doi: 10.1007/s10067-004-1067-4.13

10. Bukhari M, Lunt M, Barton A, et al. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis. 2007;66:389-93. doi: 10.1136/ard.2006.055657

11. Radovits BJ, Fransen J, Eijsbouts A, et al. Missed opportunities in the treatment of elderly patients with rheumatoid arthritis. Rheumatology (Oxford). 2009;48:906-10. doi: 10.1093/rheumatology/kep12

12. Innala L, Berglin E, Mü ller B, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2014;16:R94. doi: 10.1186/ar4540

13. Oka M, Kytila J. Rheumatoid arthritis with the onset in old age. Acta Rheumatol Scand. 1957;3:249-58. doi: 10.3109/rhe1.1957.3.issue-1-4.28

14. Adler E. Rheumatoid arthritis in old age. Isr J Med Sci. 1966;2:607-13.

15. Ehrlich GE, Katz WA, Cohen SH. Rheumatoid arthritis in the aged. Geriatrics. 1970;25:103-13.

16. Corrigan AB, Robinson RG, Terenty TR, et al Benign rheumatoid arthritis of the aged. Br Med J. 1974;1:444-6. doi: 10.1136/bmj.1.5905.444

17. MacGregor AJ. Classification criteria for rheumatoid arthritis. Baillieres Clin Rheumatol. 1995 May;9(2):287-304. doi: 10.1016/S0950-3579(05)80191-8

18. Arnett FC, Edworthy SM, Bloch DA, et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24. doi: 10.1002/art.1780310302

19. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8. doi: 10.1136/ard.2010.138461

20. Ferraccioli GF, Cavalieri F, Mercadanti M, et al Clinical features, scintiscan characteristics and X-ray progression of late onset rheumatoid arthritis. Clin Exp Rheumatol. 1984;2:157-61.

21. Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford). 1999;38:228-34. doi: 10.1093/rheumatology/38.3.228

22. Van der Heijde DM, van Riel PL, van Leeuwen MA, et al. Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. J Rheumatol. 1991;18:1285-9.

23. Satybaldyev AM. Clinico-immunologic characteristics of rheumatoid arthritis developed in old age. Voprosy Revmatizma. 1980;20(3):22-5 (In Russ.).

24. Alpizar-Rodriguez D, Pluchino N, Canny G, et al. The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology (Oxford). 2017 Aug;56(8):1254-63. doi: 10.1093/rheumatology/kew318

25. Satybaldiyev AM. Rheumatoid arthritis in the elderly. Consilium Medicum. 2007;12:85-92 (In Russ.).

26. Arnold MB, Bykerk VP, Boire G, et al; on behalf of CATCH Investigators. Are there differences between young- and olderonset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology. 2014 Jun;53(6):1075-86. doi: 10.1093/rheumatology/ket 449


Review

For citations:


Satybaldyev A.M., Demidova N.V., Gridneva G.I., Nikishina N.Yu., Gerasimova E.V., Gukasian D.A., Kasumova K.A., Luchikhina E.L., Misiyuk A.S., Oskilko T.G., Rumyantseva O.A., Zlepko E.A., Tyurina L.N., Fedorenko E.V., Shornikova N.V., Nasonov E.L. CLINICAL CHARACTERISTICS OF THREE COHORTS OF PATIENTS WITH EARLY- AND LATE-ONSET RHEUMATOID ARTHRITIS (AT 50 YEARS OR OLDER). GENERALIZATION OF 40 YEARS’ EXPERIENCE. Rheumatology Science and Practice. 2020;58(2):140-146. (In Russ.) https://doi.org/10.14412/1995-4484-2020-140-146

Views: 742


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)